Stock Yards Bank & Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-5,360
Closed -$600K – 236
2020
Q2
$600K Hold
5,360
– – 0.05% 140
2020
Q1
$415K Buy
5,360
+360
+7% +$31.9K 0.04% 146
2019
Q4
$476K Hold
5,000
– – 0.04% 157
2019
Q3
$381K Hold
5,000
– – 0.03% 167
2019
Q2
$439K Hold
5,000
– – 0.04% 163
2019
Q1
$453K Hold
5,000
– – 0.04% 158
2018
Q4
$359K Hold
5,000
– – 0.04% 162
2018
Q3
$479K Sell
5,000
-80
-2% -$7.76K 0.05% 150
2018
Q2
$484K Hold
5,080
– – 0.05% 145
2018
Q1
$446K Buy
+5,080
New +$464K 0.05% 149
2016
Q4
– Sell
-6,870
Closed -$455K – 210
2016
Q3
$455K Sell
6,870
-2,355
-26% -$146K 0.06% 144
2016
Q2
$499K Buy
+9,225
New +$505K 0.07% 150

Other funds holding XBI

Stock Yards Bank & Trust's XBI Position: Q3 2020 in Review

Stock Yards Bank & Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2020, closing a stake of 5,360 shares — an estimated $600K sold.

Stock Yards Bank & Trust first reported a position in XBI in Q2 2016 and held it in 12 quarters. The position peaked at $600K in Q2 2020. 554 funds tracked by Wall St. Rank hold XBI as of Q3 2020.

  • Stock Yards Bank & Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2020 after selling out during the quarter.
  • Stock Yards Bank & Trust sold 5,360 State Street SPDR S&P Biotech ETF shares in Q3 2020, an estimated $600K.
  • Stock Yards Bank & Trust first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and held it in 12 quarters.
  • Stock Yards Bank & Trust's State Street SPDR S&P Biotech ETF position peaked at $600K in Q2 2020.
  • 554 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2020.

Based on Stock Yards Bank & Trust's 13F filing for Q3 2020, filed 14 Oct 2020.